Showing results (11-20 of 185) with videos related to
Sort By:
Pageof 19
Biochemical Pharmacology|August 3, 1994
Interaction of p-aminophenyldichloroarsine, an arsenical with specificity for vicinal cysteines, with [3H]cytisine binding sites in rat brain membranesA Aplin, S WonnacottThe Biochemical Journal|June 15, 1976
Inhibition by botulinum toxin of depolarization-evoked release of (14C)acetylcholine from synaptosomes in vitroS Wonnacott, R M MarchbanksJournal of Neurochemistry|December 1, 1990
Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomesP P Rowell, S WonnacottNeuropharmacology|November 1, 1995
Anatoxin-a-evoked [3H]dopamine release from rat striatal synaptosomesL Soliakov, T Gallagher, S WonnacottJournal of Neuroimmunology|August 1, 1982
Immunological cross-reactivity between the alpha-bungarotoxin-binding component from rat brain and nicotinic acetylcholine receptorS Wonnacott, R Harrison, G LuntJournal of Neurochemistry|April 1, 1988
Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulationC Rapier, G G Lunt, S WonnacottActa Psychiatrica Scandinavica|June 1, 1991
Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly peopleA L Phanjoo, S Wonnacott, A HodgsonActa Neuropathologica|May 7, 2003
Clustering of neuronal inclusions in "dementia with neurofilament inclusions"N J Cairns, R A ArmstrongNeuropathology and Applied Neurobiology|February 6, 2010
Analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysisR A Armstrong, N J CairnsClinical Neuropathology|September 30, 2006
Laminar degeneration of the frontal and temporal cortex in neuronal intermediate filament inclusion disease (NIFID): a study original using alpha-internexin immunohistochemistryR A Armstrong, N J CairnsPageof 19